Sodium–glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists treatment: variable observations of sequelae on diabetic retinopathy

Kunutsor SK Khunti K Seidu S. Racial, ethnic and regional differences in the effect of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists on cardiovascular and renal outcomes: a systematic review and meta-analysis of cardiovascular outcome trials. J R Soc Med. doi: 10.1177/01410768231198442. Epub ahead of print. PMID: 37734450.

Wołos-Kłosowicz K Matuszewski W Rutkowska J Krankowska K Bandurska-Stankiewicz E. Will GLP-1 analogues and SGLT-2 inhibitors become new game changers for diabetic retinopathy? J Clin Med 2022; 11: 6183.

Nugawela MD Gurudas S Prevost AT Mathur R Robson J Hanif W , et al. Ethnic disparities in the development of sight-threatening diabetic retinopathy in a UK multi-ethnic population with diabetes: an observational cohort study. J Pers Med 2021; 11: 740.